http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100335169-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-91 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-76 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-91 |
filingDate | 1998-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2002-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2002-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-100335169-B1 |
titleOfInvention | Novel Tricyclic Compounds Having Saturated Rings and Medicinal Compositions Containing the Same |
abstract | A compound represented by the formula (I) or a salt thereof having an effective β-adrenergic receptor activity when used in a blind spot in a medicine for treating and preventing diabetes, obesity or hyperlipidemia and the like.n n n <Formula I>n n n n n n n n In the formula, R represents hydrogen or methyl group, R 1 represents hydrogen, halogen, hydroxy group, benzyloxy group, amino group or hydroxymethyl group, R 2 represents hydrogen, hydroxymethyl group, NHR 3 , S0 2 NR 4 R 4 ' Or nitro group, wherein R 3 represents hydrogen, methyl group, S0 2 R 5 , formyl group or C0NHR 6' , R 5 represents lower alkyl group, benzyl group or NR 4 R 4 ' , R 4 and R 4 ' Can be the same or different from each other, each represents hydrogen, a lower alkyl group or a benzyl group, R 6' represents a hydrogen or a lower alkyl group, R 6 represents a hydrogen or a lower alkyl group, n is 1 or 2, and X is A secondary nitrogen atom, an oxygen atom, or a sulfur atom, and when n is 1, either R 7 or R 8 is a hydrogen atom, the other represents hydrogen, an amino group, an acetylamino group or a hydroxy group, or n is 2 If, R 8 is hydrogen And, R 7 is a hydrogen, an amino group, an acetylamino group or a hydroxyl group. |
priorityDate | 1997-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 511.